Skip to main content
Clinical Trials/NCT03093987
NCT03093987
Completed
N/A

Critical Care Ultrasound Oriented Shock Treatment in ICU

West China Hospital1 site in 1 country150 target enrollmentApril 5, 2017
ConditionsShock

Overview

Phase
N/A
Intervention
Not specified
Conditions
Shock
Sponsor
West China Hospital
Enrollment
150
Locations
1
Primary Endpoint
28-day mortality
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Objective

To investigate whether critical care ultrasound oriented shock management in shock patients in intensive care unit(ICU) can improve outcome.

Methods

Randomized controlled research. Patients were randomly allocated to two groups. In the critical care ultrasound oriented shock management group (CUSS group), treatment was oriented by the findings of critical care ultrasound in each shock phase, while in the control group the decisions about the monitoring and management were made by the clinical team. The goal of treatments in both groups were decreasing lactate by 20% or more per 2 hours for the Optimization phase in shock management, and no increase lactate level when removing the fluid in de-escalation phase. The primary outcome measure were hospital mortality and 28-day mortality, the secondary outcome measure were the length of ventilation and the length of ICU stay.

Registry
clinicaltrials.gov
Start Date
April 5, 2017
End Date
October 28, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

tongjuan ZOU

Professor

West China Hospital

Eligibility Criteria

Inclusion Criteria

  • SBP \<90 mm Hg or MAP \<65 mm Hg or SBP decrease \>40mmHg or need vasoactive drugs;
  • Skin that is cold and clammy,capillary refill time \>4.5s,urine output of\<0.5ml/Kg.hr and lactate \>2mmol/L;
  • SHOCK presented within 6 hr.

Exclusion Criteria

  • \<18 years old;
  • Pregnancy;
  • Patient or family member refuse to be enrolled.

Outcomes

Primary Outcomes

28-day mortality

Time Frame: through study completion,an average of 28 days

28-day mortality

Secondary Outcomes

  • the incidence of AKI(through study completion,an average of 28 days)
  • the total length of hospital stay(through study completion,an average of 28 days)
  • the length of ICU stay(through study completion,an average of 28 days)

Study Sites (1)

Loading locations...

Similar Trials